Project-Based • Vetted • Secure

Connecting Scientific Founders
with Vetted Experts

Golgiplex accelerates Biotech startups & Labs by connecting you with top-tier consultants for Pre-IND strategy, Regulatory Affairs, Grant Writing, and Computational Biology.

*Currently in development. We are continuing to build the platform, expecting a pilot launch in Q1 2026.

Core Capabilities

Regulatory Affairs

FDA Pre-IND strategy, 505(b)(2) analysis, and compliance pathways.

Grant Writing

SBIR/STTR Phase I/II, NIH, and Foundation grant proposal development.

Pre-IND Consulting

CMC strategy, toxicology study design, and clinical development planning.

Computational Bio

Genomics analysis, AI-driven drug discovery, and bioinformatics pipelines.

Core Platform Features

Trust Infrastructure

Rigorous expert vetting process selects for top-tier, validated experts, including credential verification, reference checks, and technical interviews.

Legal & IP Protection

Built-in mutual NDAs, customizable IP assignment agreements, and pre-negotiated contracts. Secure data rooms with encrypted file sharing.

Payment Security

Escrow-based milestone payments protect both clients and experts. Funds are released upon verified deliverable completion.

Speed & Efficiency

Browse expert profiles instantly, receive proposals within 48 hours, and begin work within 1-2 weeks.

Startup Scenarios

See how Golgiplex transforms the trajectory of scientific startups.

Scenario 1

Novel Therapeutics - From University Spinout to IND

Path A: Traditional Approach

Founders pitch to VCs early but face competition and high burn rates.

The Cost Barrier:
  • Full-service CROs: $200-500K+
  • Regulatory Retainers: $75-150K
  • CMC Development: $100-300K

Outcome: Cash burn, missed milestones, failure before IND.

Path B: Golgiplex-Enabled

Strategic planning using non-dilutive grants and project-based experts.

Expert Network Deployed:
  • 🧬 Serial Founder Strategy $5-8K
  • 📝 SBIR/STTR Grant Writer $8-12K
  • ⚖️ Regulatory Affairs $12-20K
  • ⚗️ CMC Development $10-15K

Total Investment

$45-70K

Result

IND-Ready + $1.2M Grants

Scenario 2

Diagnostics Platform (AI Imaging) - Research to Clinical

Path A: Technology Focus Only

Founders build great AI but underestimate SaMD regulations and reimbursement.

The Pitfalls:
  • Lack of clinical validation data
  • No defined reimbursement pathway
  • Cannot commercialize technology

Outcome: Great tech, no business model. Runs out of funds.

Path B: Parallel Development

Simultaneous FDA submission track, clinical validation, and market access work.

Expert Network Deployed:
  • 💻 FDA SaMD Consultant $15-25K
  • 📊 Validation Study Designer $12-18K
  • 🏥 Pathology KOL Network $8-12K
  • 💰 Market Access Strategy $10-15K

Total Investment

$45-70K

Result

Validation + Series A ($5-8M)

How It Works

Five-Step Engagement Process

1

Post Project

Define scope, budget, timeline, and deliverables.

2

Get Proposals

Vetted experts submit tailored proposals within 48 hours.

3

Select & Contract

Review profiles and sign automated NDA/SOW.

4

Work & Deliver

Milestone-based payments and secure file sharing.

5

Rate & Repeat

Review quality, release funds, and build relationships.

For Biotech Companies

Tell us about your project needs. We'll connect you with the right experts.

Join as an Expert

Are you a specialized consultant in Regulatory Affairs, Comp Bio, or Grant Writing? Join the Golgiplex network to access vetted high-impact projects.

  • Access exclusive Biotech startup projects
  • Guaranteed payment & secure infrastructure
  • Flexible project-based engagements
Open Expert Interest Form →

Opens in new tab

Have general questions? We'd love to hear from you.

info@golgiplex.com